An internally covered (lined) self-expanding metal esophageal stent: tissue response in a porcine model - 16/08/11
Reprint requests: Todd H. Baron, MD, FACP, 200 First St SW, Charlton 8, Rochester, MN 55905.Rochester, Minnesota, USA
Abstract |
Background |
Self-expandable metal stents (SEMS) palliate malignant dysphagia but may embed in tissue, produce granulation tissue, and prevent removal.
Objective |
Our purpose was to evaluate in a porcine model the tissue response induced by a new esophageal SEMS completely coated internally rather than externally.
Design |
Eight Yucatan pigs were studied. Each animal underwent placement of 2 stents: 1 study stent and 1 control stent. SEMS were placed proximally or distally by random assignment. Follow-up endoscopy was performed 1, 2, 3, and 4 weeks after implantation. Ease of stent removal was assessed at 2 weeks and 4 weeks after placement.
Setting |
Animal laboratory.
Interventions |
Endoscopic placement of study stents (Alveolus ES-STS, Alveolus, Inc, Charlotte, NC; 18 mm diameter, fully covered internally) and control stents (Ultraflex stent, Boston Scientific, Natick, Mass; microvasive, 18 mm midbody, subtotally covered externally).
Main Outcome Measurements |
Extent of granulation tissue and stent-induced esophageal injury.
Results |
The tissue hyperplasia response of the study stents was endoscopically graded as mild to moderate. All study stents were endoscopically removed easily and atraumatically. Control stents produced severe granulation tissue formation with complete embedding of the uncovered stent ends; endoscopic removal was possible but resulted in trauma and endoscopically visible bleeding. Histopathologic findings revealed minimal tissue response at the ends of the study stents and severe pseudopolyps in the embedded portion of the control stent. Stent migration occurred in 7 of 8 study stents and 4 of 8 control stents.
Limitations |
Animal model lacks stricture.
Conclusions |
Fully internally lined SEMS may resist tissue embedding and hyperplasia and may be removable. Human studies are needed to assess applicability to treatment of benign and malignant esophageal disease.
Le texte complet de cet article est disponible en PDF.Plan
| Supported by a grant from Alveolus Corporation, Charlotte, North Carolina. Presented in abstract form as a poster at the 2005 annual meeting of the American Society for Gastrointestinal Endoscopy, Chicago, Illinois (Gastrointest Endosc 2005;61:AB227). |
Vol 64 - N° 2
P. 263-267 - août 2006 Retour au numéro
Article précédent
- Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma
- David S. Utley
- Dysphagia lusoria assessed by 3-dimensional CT
- Bora Keum, Yong Sik Kim, Yoon-Tae Jeen, Hoon Jai Chun, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu, Jin Hai Hyun
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?